Strumento inattivo

Azioni Rennova Health Inc Nasdaq

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	24/07/20
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	17/07/20
RENNOVA HEALTH, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	08/07/20
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	29/06/20
RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	16/06/20

Dirigenti	Titolo	Età	Da
Darrell Peterson CEO	Chief Executive Officer	65	14/05/23
Gerard Dab CHM	Chairman	75	14/05/23
Sebastien Sainsbury IRO	Public Communications Contact	61	-

Amministratori	Titolo	Età	Da
Gerard Dab CHM	Chairman	75	14/05/23
Sharon Hollis CEO	Chief Executive Officer	47	01/07/11
Francisco Roca BRD	Director/Board Member	58	14/05/23

Settore

	Variaz. 1 gen.	Capi.
SONIC HEALTHCARE LIMITED	-16,99%	8,67 Mrd
RADNET, INC.	+68,08%	4,25 Mrd
DR. LAL PATHLABS LIMITED	-1,10%	2,51 Mrd
SYNLAB AG	-9,46%	2,47 Mrd
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-44,11%	2,25 Mrd
NEOGENOMICS, INC.	-8,31%	1,91 Mrd
FLEURY S.A.	-19,29%	1,56 Mrd
DIAN DIAGNOSTICS GROUP CO.,LTD.	-41,75%	1,19 Mrd
METROPOLIS HEALTHCARE LIMITED	+11,31%	1,15 Mrd